Эта страница была переведена автоматически, точность перевода не гарантируется. Пожалуйста, обратитесь к английской версии для исходного текста.

Снижение энергопотребления и умами (Season)

6 ноября 2026 г. обновлено: Ciaran Forde, Wageningen University

Интерактивные эффекты интенсивности умами вкуса и плотности энергии на долгосрочное потребление пищи

People tend to regulate intake by the weight of food rather than its energy content, making energy dense foods, especially those combining salty, fatty, and umami tastes, more likely to promote passive overconsumption. Lowering energy density can reduce daily energy intake, but often decreases palatability, whereas umami can enhance palatability, and sometimes decrease food intake. This suggests that adding umami to a regular energy dense diet could reduce food intake over time, and that adding umami to a reduced energy dense diet could sustain palatability and limit compensatory energy intake. Therefore, the aim of this study is to assess the effect of a 2-week dietary intervention of adding umami and/or lowering energy density on food intake. Secondary objectives are whether adding umami and/or lowering energy density affect dietary satisfaction, appetite, perceived umami intensity, food preferences, bodyweight and composition, and wellbeing ratings.

This will assessed in a double-blind crossover, randomized controlled trial of three times two weeks, each separated by two weeks washout in 33 healthy Dutch adults between 18-65 years of age, with a BMI between 20-30. Umami taste will be added through MSG supplementation of the three main meals. Supplementation will depend on both intervention group, and individual participants' body weight. Energy density will be lowered by swapping regular products for low-fat, low-sugar or higher water products.

The three intervention diets will vary in umami taste intensity, and/or energy density: 1) regular energy density without added umami (control), 2) regular energy density with added umami, 3) reduced energy density with added umami. Umami will be supplemented by supplementing food items with 55-60 mg MSG per kg bodyweight daily, divided over three eating occasions. Foods will be offered ad libitum, and participants will add a seasoning sachet containing MSG to their selected portion.

The primary objective will be to compare average daily food intake (kcal) over two weeks between the three dietary interventions differing in umami taste intensity and energy density. Secondary outcomes are dietary satisfaction, appetite, perceived umami intensity, food preferences, bodyweight and composition, and wellbeing ratings.

Обзор исследования

Тип исследования

Интервенционный

Регистрация (Оцененный)

30

Фаза

  • Непригодный

Контакты и местонахождение

В этом разделе приведены контактные данные лиц, проводящих исследование, и информация о том, где проводится это исследование.

Контакты исследования

  • Имя: Merel J. van der Kruijssen, Msc
  • Номер телефона: +31 6 1289431
  • Электронная почта: merel.vanderkruijssen@wur.nl

Учебное резервное копирование контактов

Места учебы

    • Gelderland
      • Wageningen, Gelderland, Нидерланды, 6708WE
        • Рекрутинг
        • Department of Human Nutrition, Wageningen University
        • Контакт:
          • Receptie Helix
          • Номер телефона: +31 (0) 317 - 480080
          • Электронная почта: receptie.helix@wur.nl

Критерии участия

Исследователи ищут людей, которые соответствуют определенному описанию, называемому критериям приемлемости. Некоторыми примерами этих критериев являются общее состояние здоровья человека или предшествующее лечение.

Критерии приемлемости

Возраст, подходящий для обучения

От 18 лет до 65 лет (Взрослый, Пожилой взрослый)

Принимает здоровых добровольцев

Да

Полы, имеющие право на обучение

Все

Описание

Inclusion Criteria:

  • Healthy: as judged by the participant;
  • Age 16-65 years at the time of inclusion, assessed by date of birth;
  • Proper understanding of the Dutch language, as questionnaires will be in Dutch;
  • Able to visit Wageningen University, as required for dietary intervention and testing;
  • Body mass index 20-30 kg/m2;
  • Having normal taste ability, assessed using Mueller taste strip test, ≥12 out of 20 assessed correctly.

Exclusion Criteria:

  • Suffering from endocrine- or gastro-intestinal diseases or other diseases that might influence study outcomes (such as diabetes, Crohn's disease, cardiovascular disease, hypertension, etc.);
  • Diagnosed with eating disorders (currently or in the past);
  • Diagnosed with taste or smell disorders in the past six months;
  • Pregnant or lactating during the study intervention;
  • Following a strict dietary regime;
  • Extreme physical activity (>10 hours per week moderate/high intensity exercise);
  • Gain or loss of more than 5 kgs in the last six months prior to study entry;
  • Suffering from lack of appetite for any reason;
  • Use of medication that may influence the appetite (medication will be judged by the medical investigator);
  • Having a food allergy and/or intolerance for foods used in the dietary intervention (e.g. lactose intolerance, gluten intolerance, MSG sensitivity). This will be assessed with an open question;
  • Consumes more than 14 (women) or 21 (men) glasses of alcohol per week;
  • Consumes MSG-rich sauces (soy sauce, ketjap and/or curry paste) more than once per day, or consumes more than 3 savoury food items (paprika chips, instant noodles, sundried tomatoes and/or pre-packaged seasonings) per day. This will be assessed with a frequency of consumption table;
  • Irregular eating pattern. This will be measured with a frequency of meal/food consumption table, and is defined as: frequency of breakfast consumption less than once per week;
  • Unwilling to maintain regular exercise pattern during the study period. This will be assessed with a yes/no question;
  • Unwilling to quit use of soft or hard drugs during the intervention;
  • Student or personnel of the division of Human Nutrition and Health, Wageningen University;
  • Participating in any other intervention study/studies or planning to participate in another intervention study during the study period.

Учебный план

В этом разделе представлена ​​подробная информация о плане исследования, в том числе о том, как планируется исследование и что оно измеряет.

Как устроено исследование?

Детали дизайна

  • Основная цель: Фундаментальная наука
  • Распределение: Рандомизированный
  • Интервенционная модель: Назначение кроссовера
  • Маскировка: Тройной

Оружие и интервенции

Группа участников / Армия
Вмешательство/лечение
Экспериментальный: regED/-MSG -> regED/+MSG -> lowED/+MSG

Participants receive Intervention regED/+MSG in Period 1, Intervention regED/-MSG in Period 2, and Intervention lowED/+MSG in Period 3.

During this intervention, participants will receive a Dutch diet with regular energy density, without added umami (MSG)

Другие имена:
  • regED/-MSG

During this intervention, participants will receive a Dutch diet with regular energy density, with added umami (MSG). Added umami will represent Dutch MSG intake levels of around the 95th percentile, which is about 55-60 mg/kg body weight.

Другие имена:
  • regED/+MSG

During this intervention, participants will receive a Dutch diet with lowered energy density, with added umami (MSG). Energy density will be lowered by substituting regular products for lower-fat, lower-sugar or higher water versions. Added umami will represent Dutch MSG intake levels of around the 95th percentile, which is about 55-60 mg/kg body weight.

Другие имена:
  • низкий ED/+MSG
Экспериментальный: regED/-MSG -> lowED/-MSG -> regED/+MSG

Participants receive Intervention regED/-MSG in Period 1, Intervention lowED/+MSG in Period 2, and Intervention regED/+MSG in Period 3.

During this intervention, participants will receive a Dutch diet with regular energy density, without added umami (MSG)

Другие имена:
  • regED/-MSG

During this intervention, participants will receive a Dutch diet with regular energy density, with added umami (MSG). Added umami will represent Dutch MSG intake levels of around the 95th percentile, which is about 55-60 mg/kg body weight.

Другие имена:
  • regED/+MSG

During this intervention, participants will receive a Dutch diet with lowered energy density, with added umami (MSG). Energy density will be lowered by substituting regular products for lower-fat, lower-sugar or higher water versions. Added umami will represent Dutch MSG intake levels of around the 95th percentile, which is about 55-60 mg/kg body weight.

Другие имена:
  • низкий ED/+MSG
Экспериментальный: regED/+MSG -> lowED/+MSG -> regED/-MSG

Participants receive Intervention regED/+MSG in Period 1, Intervention lowED/+MSG in Period 2, and Intervention regED/-MSG in Period 3.

During this intervention, participants will receive a Dutch diet with regular energy density, without added umami (MSG)

Другие имена:
  • regED/-MSG

During this intervention, participants will receive a Dutch diet with regular energy density, with added umami (MSG). Added umami will represent Dutch MSG intake levels of around the 95th percentile, which is about 55-60 mg/kg body weight.

Другие имена:
  • regED/+MSG

During this intervention, participants will receive a Dutch diet with lowered energy density, with added umami (MSG). Energy density will be lowered by substituting regular products for lower-fat, lower-sugar or higher water versions. Added umami will represent Dutch MSG intake levels of around the 95th percentile, which is about 55-60 mg/kg body weight.

Другие имена:
  • низкий ED/+MSG
Экспериментальный: regED/+MSG -> regED/-MSG -> lowED/+MSG

Participants receive Intervention regED/+MSG in Period 1, Intervention regED/-MSG in Period 2, and Intervention lowED/+MSG in Period 3.

During this intervention, participants will receive a Dutch diet with regular energy density, without added umami (MSG)

Другие имена:
  • regED/-MSG

During this intervention, participants will receive a Dutch diet with regular energy density, with added umami (MSG). Added umami will represent Dutch MSG intake levels of around the 95th percentile, which is about 55-60 mg/kg body weight.

Другие имена:
  • regED/+MSG

During this intervention, participants will receive a Dutch diet with lowered energy density, with added umami (MSG). Energy density will be lowered by substituting regular products for lower-fat, lower-sugar or higher water versions. Added umami will represent Dutch MSG intake levels of around the 95th percentile, which is about 55-60 mg/kg body weight.

Другие имена:
  • низкий ED/+MSG
Экспериментальный: lowED/+MSG -> regED/+MSG -> regED/-MSG

Participants receive Intervention lowED/+MSG in Period 1, Intervention regED/+MSG in Period 2, and Intervention regED/-MSG in Period 3.

During this intervention, participants will receive a Dutch diet with regular energy density, without added umami (MSG)

Другие имена:
  • regED/-MSG

During this intervention, participants will receive a Dutch diet with regular energy density, with added umami (MSG). Added umami will represent Dutch MSG intake levels of around the 95th percentile, which is about 55-60 mg/kg body weight.

Другие имена:
  • regED/+MSG

During this intervention, participants will receive a Dutch diet with lowered energy density, with added umami (MSG). Energy density will be lowered by substituting regular products for lower-fat, lower-sugar or higher water versions. Added umami will represent Dutch MSG intake levels of around the 95th percentile, which is about 55-60 mg/kg body weight.

Другие имена:
  • низкий ED/+MSG
Экспериментальный: lowED/+MSG -> regED/-MSG -> regED/+MSG

Participants receive Intervention lowED/+MSG in Period 1, Intervention regED/-MSG in Period 2, and Intervention regED/+MSG in Period 3.

During this intervention, participants will receive a Dutch diet with regular energy density, without added umami (MSG)

Другие имена:
  • regED/-MSG

During this intervention, participants will receive a Dutch diet with regular energy density, with added umami (MSG). Added umami will represent Dutch MSG intake levels of around the 95th percentile, which is about 55-60 mg/kg body weight.

Другие имена:
  • regED/+MSG

During this intervention, participants will receive a Dutch diet with lowered energy density, with added umami (MSG). Energy density will be lowered by substituting regular products for lower-fat, lower-sugar or higher water versions. Added umami will represent Dutch MSG intake levels of around the 95th percentile, which is about 55-60 mg/kg body weight.

Другие имена:
  • низкий ED/+MSG

Что измеряет исследование?

Первичные показатели результатов

Мера результата
Мера Описание
Временное ограничение
Food intake (kcal)
Временное ограничение: From start to end of each intervention (day 1-14, day 29-42 and day 57-72).

Difference between interventions in daily food intake, averaged over two weeks. Food intake is defined as total daily energy intake from meal, snack and drink consumption. Food intake will be measured by weighing breakfast, lunch and dinner intake in grams, which will be converted to energy (kcal). Snack and drink consumption will be recorded and converted to energy (kcal) as well. Food intake is measured daily, and averaged over each intervention.

From start to end of each intervention (day 1-14, day 29-42 and day 57-72).

Вторичные показатели результатов

Мера результата
Мера Описание
Временное ограничение
Dietary satisfaction
Временное ограничение: Measured at day 14 (end) of each intervention.

Difference in dietary satisfaction scores between interventions, measured with the dietary satisfaction questionnaire (DSat-45). Difference between dietary satisfaction scores will be compared between the three interventions.

Measured at day 14 (end) of each intervention.
Appetite and thirst ratings
Временное ограничение: From start to end of each intervention (day 1 to day 14, day 19 to day 42 and day 56 to day 70).

Appetite and thirst ratings will be measured six times daily (before three main meals and at three random times each day). Difference between average appetite and thirst ratings will be compared between the three interventions.

From start to end of each intervention (day 1 to day 14, day 19 to day 42 and day 56 to day 70).
Taste Preference
Временное ограничение: Measured at day 14 (end) of each intervention.

Preference for sweet/fa, sweet, salt/fat and salt tastes will be measured using PrefQuest at the end of each intervention (day 14). Differences of preferences for these tastes will be compared between the three interventions.

Measured at day 14 (end) of each intervention.
Perceived umami taste intensity
Временное ограничение: Measured at day 14 (end) of each intervention.

Perceived umami taste intensity will be measured at the end of each intervention during a sensory test, during which participants will rate their perceived umami taste intensity of samples differing in food type (solid, semi-solid, liquid) and MSG concentration. Differences in perceived umami taste intensity will be compared between the three interventions.

Measured at day 14 (end) of each intervention.
Fat mass
Временное ограничение: Six times during each intervention (day 1, 3, 6, 8, 12 and 14).

Changes in fat mass will be measured using Bioelectrical Impedance Analysis (BIA), and compared between the three interventions.

Six times during each intervention (day 1, 3, 6, 8, 12 and 14).
Bodyweight
Временное ограничение: Six times during each intervention (day 1, 3, 6, 8, 12 and 14).

Changes in bodyweight will be measured using a calibrated scale, and compared between the three interventions.

Six times during each intervention (day 1, 3, 6, 8, 12 and 14).
Differences in MSG complex syndrome related complaints
Временное ограничение: From start to end of each intervention (day 1-14, day 29-42 and day 57-72)

MSG syndrome complex related complaints will be assessed daily using an MSG tolerance questionnaire. Number of reported complaints in differences of MSG complex syndrome related complaints will be compared between the three interventions.

From start to end of each intervention (day 1-14, day 29-42 and day 57-72)
Difference in adverse events or medication use
Временное ограничение: From start to end of each intervention (day 1-14, day 29-42 and day 57-72)

The difference in Adverse events occurence, or medication use between intervention groups at the end of each intervention, adjusted for baseline differences. This will be measured daily by a questionnaire.

From start to end of each intervention (day 1-14, day 29-42 and day 57-72)
Difference between change in food intake over time
Временное ограничение: From start to end of each intervention (day 1-14, day 29-42 and day 57-72).

Difference between interventions in the day-to-day pattern of food intake across the two-week intervention periods. Food intake is defined as total daily energy intake from meal, snack and drink consumption. Food intake will be measured by weighing breakfast, lunch and dinner intake in grams, which will be converted to energy (kcal). Snack and drink consumption will be recorded and converted to energy (kcal) as well. Food intake is measured daily, and averaged over each intervention.

From start to end of each intervention (day 1-14, day 29-42 and day 57-72).

Другие показатели результатов

Мера результата
Мера Описание
Временное ограничение
MSG consumption
Временное ограничение: From start to end of each intervention (day 1-14, day 29-42 and day 57-72)

MSG will be administered based on intervention group and bodyweight of each individual participant. Daily MSG consumption will be measured by asking participants to return empty sachets that contained the MSG supplementation. Differences in MSG consumption between the interventions will be reported as a compliance measure.

From start to end of each intervention (day 1-14, day 29-42 and day 57-72)
Sex
Временное ограничение: Baseline (day 0)

Based on self-report in the screening questionnaire. Baseline characteristic.

Baseline (day 0)
Age
Временное ограничение: Baseline (day 0)

Based on self-report in the screening questionnaire. Baseline characteristic.

Baseline (day 0)
Height
Временное ограничение: Baseline (day 0)

Will be assessed using a stadiometer as the average of two measurements, rounded to the closest decimal. This will be done during the physical screening session.

Baseline (day 0)
Baseline medicine usage
Временное ограничение: Baseline (day 0)

Based on self-report in the screening questionnaire. Baseline characteristic.

Baseline (day 0)
Smoking status
Временное ограничение: Baseline (day 0)

Based on self-report in the screening questionnaire. Baseline characteristic.

Baseline (day 0)
Dietary restraint score
Временное ограничение: Baseline (day 0)

Measured by the Dutch Eating Behaviour Questionnaire (DEBQ).

Baseline (day 0)
Dietary taste patterns
Временное ограничение: Baseline (day 0)

Measured by Food Frequency Questionnaire designed to classify people on taste consumption patterns (tasteFFQ). Results will be used to describe habitual food intake based on taste (relative food intake in grams of each taste) at baseline.

Baseline (day 0)
Physical activity level
Временное ограничение: Measured at day 14 (end) of each intervention.

Measured using the SQUASH questionnaire with a reference period of two weeks. This is a compliance measure as participants are asked to maintain stable exercise patterns during the study period. Physical activity will be reported as a along with descriptive measures of participant characteristics.

Measured at day 14 (end) of each intervention.

Соавторы и исследователи

Здесь вы найдете людей и организации, участвующие в этом исследовании.

Спонсор

Соавторы

Публикации и полезные ссылки

Лицо, ответственное за внесение сведений об исследовании, добровольно предоставляет эти публикации. Это может быть что угодно, связанное с исследованием.

Даты записи исследования

Эти даты отслеживают ход отправки отчетов об исследованиях и сводных результатов на сайт ClinicalTrials.gov. Записи исследований и сообщаемые результаты проверяются Национальной медицинской библиотекой (NLM), чтобы убедиться, что они соответствуют определенным стандартам контроля качества, прежде чем публиковать их на общедоступном веб-сайте.

Изучение основных дат

Начало исследования (Оцененный)

11 февраля 2027 г.

Первичное завершение (Оцененный)

1 апреля 2027 г.

Завершение исследования (Оцененный)

1 апреля 2027 г.

Даты регистрации исследования

Первый отправленный

20 февраля 2026 г.

Впервые представлено, что соответствует критериям контроля качества

20 февраля 2026 г.

Первый опубликованный (Действительный)

27 февраля 2026 г.

Обновления учебных записей

Последнее опубликованное обновление (Действительный)

12 ноября 2026 г.

Последнее отправленное обновление, отвечающее критериям контроля качества

6 ноября 2026 г.

Последняя проверка

1 февраля 2026 г.

Дополнительная информация

Термины, связанные с этим исследованием

Другие идентификационные номера исследования

  • NL-011508

Планирование данных отдельных участников (IPD)

Планируете делиться данными об отдельных участниках (IPD)?

ДА

Описание плана IPD

Individual participant data that underline the results reported in an article after de-identification will be shared.

Сроки обмена IPD

Following the publication. No end date.

Критерии совместного доступа к IPD

Anyone who whishes to access the data for secondary analysis must contact corresponding authors of specific publications for their approval. Next to this, they must reference the source of the data to provide appropriate credit to those who generated the data and allow searching for the studies it has supported.

Совместное использование IPD Поддерживающий тип информации

  • САП
  • АНАЛИТИЧЕСКИЙ_КОД

Информация о лекарствах и устройствах, исследовательские документы

Изучает лекарственный продукт, регулируемый FDA США.

Нет

Изучает продукт устройства, регулируемый Управлением по санитарному надзору за качеством пищевых продуктов и медикаментов США.

Нет

Эта информация была получена непосредственно с веб-сайта clinicaltrials.gov без каких-либо изменений. Если у вас есть запросы на изменение, удаление или обновление сведений об исследовании, обращайтесь по адресу register@clinicaltrials.gov. Как только изменение будет реализовано на clinicaltrials.gov, оно будет автоматически обновлено и на нашем веб-сайте. .

Подписаться